1-20 of 25
Pierre Sesques
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients

Gabriel Antherieu, Edith Julia, Alizee Maarek, Violaine Safar, Emmanuelle Ferrant, Alexandra Traverse-Glehen, Anne Lazareth, Helene Lequeu, Stéphanie Cordeil, Guillaume Aussedat, Camille Golfier, Dana Ghergus, Pierre Sesques, Lionel Karlin, Fadhela Bouafia Sauvy, Gilles Salles, Emmanuel Bachy, Emmanuel Jouanneau, Francois Ducray, Loic Boussel, Herve Ghesquieres
Journal: Blood
Blood (2023) 142 (Supplement 1): 1764.
https://doi.org/10.1182/blood-2023-179765
Published: 2023
Journal Articles

The Post-CAR Prognostic Index (PC-PI): A New Prognostic Score to Predict Overall Survival in Large B-Cell Lymphoma Patients Progressing after Chimeric Antigen Receptor T-Cell Therapy

Gloria Iacoboni, Victor Navarro Garces, Josu Iraola, Pierre Sesques, Kai Rejeski, Fabio Serpenti, Mariana Bastos-Oreiro, ANA Africa Martin Lopez, Javier Delgado, Ariadna Perez, Manuel Guerreiro, Ana Carolina Caballero Gonzalez, Nuria Martinez-Cibrian, Hugo Daniel Luzardo Henriquez, Jose Maria Sanchez Pina, Juan-Manuel Sancho, Herve Ghesquieres, Alberto Mussetti, Pere Barba, Lucia Lopez Corral, Rafael Hernani, Juan Luis Reguera, Anna Maria Sureda Balari, Francesc Bosch, Alejandro Martin Garcia-Sancho, Mi Kwon, Andrea Kuhnl, Marion Subklewe, Emmanuel Bachy, Guillermo Villacampa, Pau Abrisqueta Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 227.
https://doi.org/10.1182/blood-2023-184942
Published: 2023
Journal Articles

Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry

Yassine Al Tabaa, Clément Bailly, Xavier Pallard, Anne Ségolène Cottereau, Jérémie Tordo, Pierre Sesques, Guillaume Cartron, Roch Houot, Roberta Di Blasi, Salim Kanoun, Caroline Milin, Françoise Kraeber-Bodéré, Laetitia Vercellino
Journal: Blood
Blood (2023) 142 (Supplement 1): 3019.
https://doi.org/10.1182/blood-2023-185794
Published: 2023
Journal Articles

Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study

Pierre Sesques, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loic Ysebaert, Fabrice Jardin, Choquet Sylvain, Jacques-Olivier Bay, Francois Xavier Gros, Franck Morschhauser, Olivier Casasnovas, Thomas Gastinne, Catherine Thieblemont, Magalie Joris, Laure Ricard, Caroline Regny, Laurianne Drieu La Rochelle, Pierre Feugier, Ambroise Marcais, Karin Tarte, Camille Laurent, Guillaume Cartron
Journal: Blood
Blood (2023) 142 (Supplement 1): 893.
https://doi.org/10.1182/blood-2023-177703
Published: 2023
Journal Articles

Synthetic Control Arm from Clinical Trials and Real-World Data from Lysa Group for Untreated Diffuse Large B Cell Lymphoma Patients Aged over 80 Years: A Bona Fide S trategy for Innovative Clinical Trials

Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, Herve Ghesquieres, Frederic Peyrade, Fabrice Jardin, Stephanie Guidez, Fontanet Delices Bijou, Pierre Sesques, Cédric Rossi, Luc Matthieu Fornecker, Ludovic Fouillet, Sylvain Carras, Benoit Tessoulin
Journal: Blood
Blood (2023) 142 (Supplement 1): 72.
https://doi.org/10.1182/blood-2023-177708
Published: 2023
Journal Articles

A Genomic Approach for High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results

Yann Guillermin, Pierre Sesques, Claire Mauduit, Arsène Vacherot, Marie-Charlotte Laude, Anne-Sophie Michallet, Catherine Chassagne, Alexandra Traverse-Glehen, Emmanuel Beillard
Journal: Blood
Blood (2023) 142 (Supplement 1): 6097.
https://doi.org/10.1182/blood-2023-182979
Published: 2023
Journal Articles

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

CME Clinical Trials & Observations
Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Olivier Casasnovas, Jacques Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
Journal: Blood
Blood (2022) 140 (24): 2584–2593.
https://doi.org/10.1182/blood.2022016945
Published: 2022
Journal Articles

Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort « Real World Data in Lymphoma and Survival in Adults » (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital

Caroline LE Lan, Aurelien Belot, Camille Golfier, Berenice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Alexandra Marquet, Emmanuelle Ferrant, Anne Lazareth, Helene Lequeu, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Salles, Fanny Cherblanc, Emmanuel Bachy, Herve Ghesquieres
Journal: Blood
Blood (2022) 140 (Supplement 1): 5210–5211.
https://doi.org/10.1182/blood-2022-164552
Published: 2022
Journal Articles

The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M. Logue, Ciara L. Freeman, Melissa Alsina, Sebastian Theurich, Frederick L. Locke, Emmanuel Bachy, Michael D. Jain, Yi Lin, Marion Subklewe
Journal: Blood
Blood (2022) 140 (Supplement 1): 7506–7508.
https://doi.org/10.1182/blood-2022-165266
Published: 2022
Journal Articles

A Genomic Approach in High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results

Arsène Vacherot, Emmanuel Beillard, Catherine Chassagne-Clément, Marie-Charlotte Laude, Pierre Sesques, Laure Lebras, Alexandra Traverse-Glehen, Claire Mauduit, Mauricette Michallet, Stéphane Morisset, Anne-Sophie Michallet, Yann Guillermin
Journal: Blood
Blood (2022) 140 (Supplement 1): 11878–11879.
https://doi.org/10.1182/blood-2022-169510
Published: 2022
Journal Articles

Causes and Risk Factors of Early and Late Non-Relapse Mortality after CD19 CAR T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Lysa Study from the Descar-T Registry

Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Marie Thérèse Rubio, Xavier Leleu, Mohamad Mohty, René-Olivier Casasnovas, Magalie Joris, Cristina Castilla-LLorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 1859–1861.
https://doi.org/10.1182/blood-2022-167840
Published: 2022
Journal Articles

The CAR-Hematotox Score Identifies Patients at High Risk for Hematological Toxicity, Infections and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in Relapsed/Refractory Mantle Cell Lymphoma

Kai Rejeski, Yucai Wang, Omar Albanyan, Javier L Munoz, Pierre Sesques, Gloria Iacoboni, Lucía López Corral, Razan Mohty, Martin Dreyling, Frederick L. Locke, Pere Barba, Emmanuel Bachy, Yi Lin, Marion Subklewe, Michael D. Jain
Journal: Blood
Blood (2022) 140 (Supplement 1): 651–653.
https://doi.org/10.1182/blood-2022-167329
Published: 2022
Journal Articles

Outcome in Multiple Myeloma Patients Treated in the Era of Modern Therapies Who Were Admitted to Intensive Care: A Retrospective Analysis from a Teaching Hospital between 2014 and 2019

Zofia Gross, Maryam Idlhaj, Lionel Karlin, Arnaud Friggeri, Anne Lazareth, Camille Golfier, Helene Lequeu, Fadhela Bouafia Sauvy, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Gilles Salles, Emmanuel Bachy, Florent Wallet, Herve Ghesquieres
Journal: Blood
Blood (2022) 140 (Supplement 1): 13099–13101.
https://doi.org/10.1182/blood-2022-165911
Published: 2022
Journal Articles

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez, Pierre Sesques, Eva Hoster, Carolina Berger, Liv Jentzsch, Dimitrios Mougiakakos, Lisa Frölich, Josephine Ackermann, Veit Bücklein, Viktoria Blumenberg, Christian Schmidt, Laurent Jallades, Boris Fehse, Christoph Faul, Philipp Karschnia, Oliver Weigert, Martin Dreyling, Frederick L. Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Bethge, Francis Ayuk, Emmanuel Bachy, Gilles Salles, Michael D. Jain, Marion Subklewe
Journal: Blood
Blood (2021) 138 (24): 2499–2513.
https://doi.org/10.1182/blood.2020010543
Published: 2021
Includes: Supplemental data
Journal Articles

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Cartron, David Beauvais, Louise Roulin, Francois Xavier Gros, Choquet Sylvain, Pierre Bories, Marie Thérèse Rubio, Rene-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Jean Jacques Tudesq, Isabelle Chaillol, Florence Broussais, Catherine Thieblemont, Roch Houot, Franck Morschhauser
Journal: Blood
Blood (2021) 138 (Supplement 1): 92.
https://doi.org/10.1182/blood-2021-150721
Published: 2021
Journal Articles

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, Francois Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Rene-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
Journal: Blood
Blood (2021) 138 (Supplement 1): 885.
https://doi.org/10.1182/blood-2021-150994
Published: 2021
Journal Articles

Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Anne Mea Spanjaart, Per Ljungman, Rafael De La Camara, Gloria Tridello, Valentín Ortiz-Maldonado, Alvaro Urbano-Ispizua, Pere Barba, Mi Kwon, Dolores Caballero, Pierre Sesques, Emmanuel Bachy, Roberta Di Blasi, Catherine Thieblemont, Friso Calkoen, Pim G.N.J. Mutsaers, Johan A. Maertens, Livia Giannoni, Emma Nicholson, Matthew P. Collin, Carlos Pinho Vaz, Elisabetta Metafuni, Joaquín Martínez-López, Fiona Dignan, Josep-Maria Ribera, Arnon Nagler, František Folber, Robin Sanderson, Adrian Bloor, Fabio Ciceri, Nina Knelange, Francis A. Ayuk, Nicolaus Kröger, Marie José Kersten, Stephan Mielke
Journal: Blood
Blood (2021) 138 (Supplement 1): 2818.
https://doi.org/10.1182/blood-2021-149466
Published: 2021
Journal Articles

R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers

Vincent Camus, Alina Berriolo-Riedinger, Justine Lequesne, David Tonnelet, MD, Pierre Decazes, Cédric Rossi, MD PhD, Pierre Sesques, MD, Corinne Haioun, MD PhD, Eric Durot, MD, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles, MD, Chloe Antier, Julien Lazarovici, MD, Helene Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, MDPhD, Laure Lebras, MD, Choquet Sylvain, Katell Le Du, MD, Christophe Bonnet, MD, Sarah Bailly, MD, Damaj Gandhi Laurent, MD PhD, Kamel Laribi, MD, Herve Maisonneuve, MD, Roch Houot, MDPhD, Adrien Chauchet, MD, Fabrice Jardin, MD PhD, Stephanie Becker, MD, Herve Tilly, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136600
Published: 2020
Journal Articles

Diagnosis-to-Treatment Interval Is an Important Prognostic Factor with a Time-Dependent Effect Predicting Event-Free Survival after 12 Months from First-Line Treatment in Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma

Marie-Charlotte Laude, Edith Julia, Emmanuelle Nicolas-Virelizier, MD, Gabriel Antherieu, Violaine Safar, Philippe Rey, MD, Emmanuelle Ferrant, MD, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clément, MD, David Meyronet, MD PhD, Anne Lazareth, MD, Helene Lequeu, MD, Camille Golfier, MD, Gabriel Brisou, MD, Dana Ghergus, MD, Pierre Sesques, MD, Lionel Karlin, MD, Gilles Salles, MDPhD, Emmanuel Bachy, MD PhD, François Ducray, MD PhD, Fadhela Bouafia, MD, Youenn Drouet, PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–45.
https://doi.org/10.1182/blood-2020-138789
Published: 2020
Journal Articles

Retrospective Evaluation of Rituximab, Methotrexate, Procabazine, Vincristine and Etoposide Followed By Consolidation with Rituximab, Aracytine and Ifosfamide for Elderly Patients with Newly Diagnosed Primary CNS Lymphoma

Gabriel Antherieu, PhD, Edith Julia, Emmanuelle Nicolas-Virelizier, MD, Marie-Charlotte Laude, Violaine Safar, Philippe Rey, MD, Emmanuelle Ferrant, MD, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clément, MD, David Meyronet, MD PhD, Anne Lazareth, MD, Helene Lequeu, MD, Camille Golfier, MD, Gabriel Brisou, MD, Dana Ghergus, MD, Pierre Sesques, MD, Lionel Karlin, MD, Fadhela Bouafia, MD, Gilles Salles, MDPhD, Emmanuel Bachy, MD PhD, François Ducray, MD PhD, Youenn Drouet, PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-139946
Published: 2020